Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Researchers Identify How Two People Controlled HIV After Stopping Treatment
    29 October 2021

    Researchers Identify How Two People Controlled HIV After Stopping Treatment

    Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision. This information could inform efforts to develop new tools to help people with HIV put the virus into remission without taking lifelong medication, which can have long-term side-effects.

  • 28 October 2021
    Systemic lupus erythematosus linked to altered gut microbiome

    Systemic lupus erythematosis (SLE) is an autoimmune disease in which the immune system targets tissues of the body, causing widespread inflammation and affecting multiple organs such as the kidney and the brain. The gut microbiome all the micro-organisms that live in the human gut is known to be altered in SLE patients. Now, a research team at Osaka University has comprehensively profiled the associations between the gut microbiome and SLE.

  • 28 October 2021
    Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic T Cell Therapies Addressing Solid Tumors

    Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire GammaDelta Therapeutics Limited (“GammaDelta”), a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy. Through the acquisition, Takeda will obtain GammaDelta’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy platforms, which includes both blood-derived and tissue-derived platforms, in addition to early-stage cell therapy programs.

  • 27 October 2021
    Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function

    Vifor Pharma andAngion Biomedica Corp announced that the phase-III trial of Angion’s ANG-3777 did not demonstrate a statistically significant difference from placebo on the primary endpoint (eGFR at 12 months) in the population of deceased donor kidney transplant patients who were at risk for developing DGF.

  • 25 October 2021
    Silver Bullet Therapeutics Launches OrthoFuzIon Bone Screw System

    Silver Bullet Therapeutics, Inc a privately-held medical device company, announced today that it is formally launching its antimicrobial OrthoFuzIon Bone Screw System at the DKOU German Congress of Orthopedics and Traumatology on October 26-29 in Berlin.

    Silver Bullet Therapeutics OrthoFuzIon product line will be featured at the Argomedical booth at Nr. 61 in Hall 4.2.

  • 25 October 2021
    Roche launches comprehensive genomic profiling kit

    Roche announced that it has launched the AVENIO Tumor Tissue CGP Kit. The Kit complements the current CGP portfolio offered by Roche and Foundation Medicine and allows laboratories to expand their oncology research in-house. Ultimately, a future version of the kit may lead to additional resources for clinicians to use in the diagnosis and treatment of cancer.

  • 25 October 2021
    CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints

    Novartis announced that the CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints of overall survival (OS) and progression-free survival (PFS) in patients treated with canakinumab (ACZ885) combined with pembrolizumab plus platinum-based doublet chemotherapy, compared to patients receiving placebo in combination with pembrolizumab plus platinum-based doublet chemotherapy.

  • 23 October 2021
    PCI elected Young executive member in its panel

    President of Gujarat Pharmacy Council Dr. Montukumar Patel has won the election of executive member in pharmacy council of India (PCI). Dr. Montukumar Patel was elected unopposed as executive member. He was also became youngest president of Gujarat State Pharmacy Council few years back.

    Years later, Gujarati youth got a place in Delhi Pharmacy Council of India. Dr. Montukumar was elected as the youngest executive member in the history of India.With 76 thousand registered pharmacists in Gujarat and 12 lakh pharmacists across India will get benefit from young panel.

  • 23 October 2021
    Advanced Radiation Therapy, LLC and Apollo Healthcare Announce Strategic Partnership

    Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have today announced a strategic partnership aimed at easing the challenge radiation oncology clinics have in pre-authorizing patients for insurance coverage for innovative radiation cancer therapies.

  • 23 October 2021
    FDA approves Susvimo for macular degeneration

    Roche announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo  (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of people with neovascular or wet age-related macular degeneration (nAMD) who have previously responded to at least two anti-vascular endothelial growth factor (VEGF) injections. Neovascular AMD is a potentially blinding condition that requires treatment with eye injections as often as once a month.

Subscribe to Pharma News